COMBIPATCH (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM) .05/.14 mg/d Patch, Extended Release
Also known as Estradiol/Norethindrone Acetate Transdermal System. Coverage in Connecticut, Massachusetts, Rhode Island and Vermont (CMS PDP Region 02).
Not on any stand-alone Part D formulary in Connecticut, Massachusetts, Rhode Island and Vermont
None of the 11 stand-alone Part D (PDP) plans in CMS PDP Region 02 list this drug. On one of those plans the patient would pay the full retail price, or you would need a formulary exception.
26 Medicare Advantage plans in CT, MA, RI, VT do cover it
Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. CT: 3 plans · MA: 16 plans · RI: 5 plans · VT: 2 plans.